Clinical Practice Guideline for the Use of Systemic Testosterone for HSDD published

ISSWSH publishes Clinical Practice Guideline for the Use of Systemic Testosterone for HSDD, an in-depth, detailed evidence-based, peer-reviewed international guideline on how healthcare professionals should administer testosterone to postmenopausal women.

This publication is so important that it appears simultaneously in three academic journals: The Journal of Sexual Medicine; Climacteric, and The Journal of Women’s Health. Although women naturally produce significant quantities of testosterone from puberty on, by the time they reach menopause, about 50% of their body’s testosterone has been lost. Such deficiency leads to reduced muscle mass and strength, increased body fat, and not infrequently to the sexual dysfunction commonly referred to as lost libido. Read the full press release here.

Save the Date

ISSWSH Annual Meeting 2021

March 5-7, 2021  
Virtual
Registration open for on-demand viewing

ISSWSH Fall Course 2021

October 7-10, 2021   116 days left
DoubleTree Resort - Paradise Valley - Scottsdale, AZ
Visit the Course Website

ISSWSH Annual Meeting 2022

March 3-6, 2022   266 days left
Renaissance Dallas Hotel - Dallas, TX
Visit the Meeting Website

Latest Tweets

Women's sexual health is not a niche! The global femtech market is estimated to grow to over $3.04 billion by the… https://t.co/W00JvAjMLU ISSWSH
Tools of the Patriarchy: The Weaponization of Sexual Freedom. #sexuallib https://t.co/i75LzLIw9C ISSWSH
IOSS is hosting a special online symposium on June 25 in memory of friend & colleague, Dr. Ariel Gustavo Scafuri. F… https://t.co/66KGiexNt3 ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow Us

On Twitter
On Facebook
On Instagram